It may well be stated that routine laboratories have been overwhelmed with requests for determination of 25-hydroxyvitamin D, the analyte reflecting vitamin D status. The number of test requests is increasing pretty much from year to year in essentially all known laboratory settings.
Given the pandemic of vitamin D insufficiency experienced on a global scale it is important to understand the laboratory implications pertaining to the determination of this not so easy analyte.
Similarly to quite a few other hormone determinations, harmonization and standardization is a valid issue and professional bodies have set up task forces to resolve the discrepancies experienced between the different currently available methodologies.
In the first article of three from this thematic issue, In the third article, Bhattoa summarizes the importance of determination of biochemical markers of bone turnover in metabolic bone diseases. Given the sensitive nature of their determination, pre-analytical, analytical and post-analytical issues are extensively discussed and their clinical utility is placed in perspective.
